Celltrion Healthcare Receives ISO 37301 Certification for 'Compliance Management'

Certification Acquired in a Total of 7 Areas Including Accounting and Tax, Fair Trade, and Corruption Prevention

Celltrion Healthcare announced on the 17th that it has obtained the 'ISO 37301' certification, an international standard compliance management system, from the British Standards Institution (BSI), a global certification body.

On the 17th, at the 'Compliance Management System ISO 37301 Certification Award Ceremony' held at Celltrion Healthcare's headquarters in Songdo, BSI Korea CEO Lim Seong-hwan (left) and Celltrion Healthcare CEO Kim Hyung-gi are posing for a commemorative photo. Photo by Celltrion Healthcare

ISO 37301 is an international certification standard established by the International Organization for Standardization (ISO) in 2021. It evaluates whether a company's compliance policies and management of legal risks are aligned with global standards and effectively operated. This certification is used as a benchmark for compliance management evaluation and is widely recognized, including by global ESG (Environmental, Social, and Governance) rating agencies.

Through an audit by BSI Korea branch, Celltrion Healthcare obtained certification in seven areas: accounting and taxation, fair trade, anti-corruption, capital market law, export regulations, labor law, and IT compliance. The company explained that this recognition confirms it as an enterprise equipped with a compliance management system and the capability to operate it smoothly.

Celltrion Healthcare, which directly sells pharmaceuticals in global markets such as the United States and Europe, has been operating a compliance support team since 2017 to manage compliance systems at its headquarters and overseas subsidiaries. The company also stated that it continuously strengthens related activities to enhance the social and governance aspects of ESG.

Kim Hyung-ki, CEO of Celltrion Healthcare, said, "Through this ISO 37301 certification, we have created an opportunity to increase trust among various stakeholders who encounter Celltrion Group’s pharmaceuticals as a company practicing ethical management." He added, "We will further solidify our preventive system against legal compliance risks and, based on this, strengthen our global business competitiveness while continuing the core value of a biopharmaceutical company that improves patients’ quality of life through transparent and fair commercial activities."

Meanwhile, Celltrion Healthcare explained that even after the merger with Celltrion is completed, maintenance certification for the same areas will be conducted within the sales and marketing organization of the merged entity. The ISO certification requires annual follow-up audits for system maintenance.

This content was produced with the assistance of AI translation services.